Literature DB >> 9586587

Participation of P450-dependent oxidation of isoniazid in isonicotinic acid formation in rat liver.

Y Ono1, X Wu, A Noda, H Noda, T Yoshitani.   

Abstract

By determining the formation amount of isonicotinic acid (INA) from isonicotinic acid hydrazide (isoniazid:INH) in isolated rat hepatocytes, we were able to identify the involvement of the oxidative cleavage of the acid hydrazide. INA formation from INH increased significantly using the isolated hepatocytes prepared from rats pretreated with phenobarbital (PB), 3-methylcholanthrene (3MC), dexamethazone (DEX) and rifampicin (RIF), respectively, in comparison to the control group. On the other hand, a remarkable decrease in INA formation from INH was observed by the addition of such P450 inhibitor as metyrapone or cimetidine as well as an amidase inhibitor bis(p-nitrophenyl)phosphate (BNPP) to the isolated hepatocytes prepared from PB-pretreated rats. By further experiments using rat hepatic microsomes, the oxidative pathway of INA formation in INH metabolism was determined to be P450-dependent, since NADPH and oxygen were both essential for the oxidative pathway of INH to INA and the amount of INA formation was also significantly increased by P450 inducers. Regarding acetylisoniazid (AcINH) and isonicotinic acid amide (INAA), however, INA formation by P450 was little observed in the microsomal experiments.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9586587     DOI: 10.1248/bpb.21.421

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  4 in total

1.  In vitro and in vivo metabolism of the anti-cancer agent CI-1040, a MEK inhibitor, in rat, monkey, and human.

Authors:  Paul A Wabnitz; David Mitchell; David A M Wabnitz
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

Review 2.  The pregnane X receptor in tuberculosis therapeutics.

Authors:  Amina I Shehu; Guangming Li; Wen Xie; Xiaochao Ma
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-12-05       Impact factor: 4.481

3.  Gender-Dimorphic Impact of PXR Genotype and Haplotype on Hepatotoxicity During Antituberculosis Treatment.

Authors:  Jann Yuan Wang; Ching Hui Tsai; Yungling Leo Lee; Li Na Lee; Chia Lin Hsu; Hsiu Ching Chang; Jong Ming Chen; Cheng An Hsu; Chong Jen Yu; Pan Chyr Yang
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

4.  Association of PXR and CAR Polymorphisms and Antituberculosis Drug-Induced Hepatotoxicity.

Authors:  Yu Wang; Xi Xiang; Wei-Wei Huang; Andrew J Sandford; Shou-Quan Wu; Miao-Miao Zhang; Ming-Gui Wang; Guo Chen; Jian-Qing He
Journal:  Sci Rep       Date:  2019-02-18       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.